Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies

Ellen Yang1, Adnan Husein1, Jose Martinez-Perez1

  • 1Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Abstract

Insights

A rare case of myelin oligodendrocyte glycoprotein (MOG) antibody disease presented as severe myelitis following COVID-19 infection. This highlights the need for urgent diagnosis and treatment of post-COVID-19 neurological complications.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Myelin oligodendrocyte glycoprotein (MOG) antibody disease typically presents as optic neuritis, but myelitis is also a possible manifestation.
  • Neurological complications following COVID-19 infection are increasingly recognized, though MOG antibody disease in this context is rare.

Observation:

  • A 57-year-old man developed acute anuria, paresthesia, and paraplegia three weeks after resolving COVID-19 symptoms.
  • Initial diagnosis of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) led to minimal improvement.

Findings:

  • The patient was diagnosed with longitudinally extensive transverse myelitis.
  • Cerebrospinal fluid analysis confirmed the presence of MOG antibodies.

Implications:

  • This case underscores the importance of considering MOG antibody disease in patients with myelitis post-COVID-19.
  • Early diagnosis and treatment, including steroids and physical therapy, are crucial for managing these rare neurological sequelae.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
35